CytomX Therapeutics (CTMX) Stock Chart & Stock Price History $1.15 +0.01 (+0.88%) (As of 10/9/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CytomX Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance-8.00%3 Month Performance-14.81%6 Month Performance-43.35%Year-To-Date Performance-25.81%1 Year Performance-5.74% Receive CTMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.Go here now for this breaking story. CTMX Stock Chart for Wednesday, October, 9, 2024 CTMX Chart by TradingView CytomX Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/08/2024$1.17$1.14-2.56%$1.16$1.12203,546 shs$88.83 million10/07/2024$1.15$1.17+1.74%$1.19$1.13326,298 shs$91.17 million10/04/2024$1.13$1.15+1.77%$1.16$1.10291,123 shs$89.61 million10/03/2024$1.15$1.13-1.74%$1.16$1.11373,128 shs$88.05 million10/02/2024$1.15$1.15$1.17$1.14396,520 shs$89.61 million10/01/2024$1.18$1.15-2.54%$1.18$1.13388,726 shs$89.61 million Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/30/2024$1.20$1.18-1.67%$1.23$1.18207,930 shs$91.94 million09/27/2024$1.20$1.20$1.27$1.17806,306 shs$93.50 million09/26/2024$1.17$1.20+2.56%$1.20$1.16523,967 shs$93.50 million09/25/2024$1.19$1.17-1.68%$1.21$1.151.60 million shs$91.40 million09/24/2024$1.15$1.19+3.48%$1.21$1.143.53 million shs$92.72 million09/23/2024$1.19$1.15-3.36%$1.19$1.12815,817 shs$89.61 million09/20/2024$1.17$1.19+1.71%$1.24$1.11972,618 shs$92.72 million09/19/2024$1.19$1.17-1.68%$1.24$1.14693,812 shs$91.17 million09/18/2024$1.21$1.19-1.65%$1.25$1.19851,194 shs$92.72 million09/17/2024$1.21$1.21$1.26$1.20653,282 shs$94.28 million09/16/2024$1.23$1.21-1.63%$1.26$1.20412,071 shs$94.53 million09/13/2024$1.25$1.23-1.60%$1.29$1.23524,514 shs$96.09 million09/12/2024$1.31$1.25-4.58%$1.30$1.25294,963 shs$97.40 million09/11/2024$1.31$1.31$1.33$1.28305,492 shs$102.34 million09/10/2024$1.25$1.31+4.80%$1.33$1.21651,511 shs$102.34 million09/09/2024$1.20$1.25+4.17%$1.30$1.20741,815 shs$97.65 million09/06/2024$1.18$1.20+1.69%$1.23$1.19983,687 shs$93.50 million09/05/2024$1.25$1.18-5.60%$1.25$1.17461,633 shs$91.94 million09/04/2024$1.12$1.25+11.61%$1.27$1.101.40 million shs$97.40 million09/03/2024$1.18$1.12-5.08%$1.20$1.12280,472 shs$87.27 million09/02/2024$1.18$1.18$1.18$1.14208,900 shs$92.18 million08/30/2024$1.15$1.18+2.61%$1.18$1.14208,674 shs$91.94 million08/29/2024$1.16$1.15-0.86%$1.18$1.14296,568 shs$89.61 million08/28/2024$1.19$1.16-2.52%$1.19$1.14221,082 shs$90.39 million08/27/2024$1.19$1.19$1.19$1.16222,316 shs$92.72 million08/26/2024$1.21$1.19-1.65%$1.24$1.16395,391 shs$92.72 million08/23/2024$1.19$1.21+1.68%$1.23$1.18296,911 shs$94.28 million08/22/2024$1.27$1.19-6.30%$1.27$1.18823,521 shs$92.72 million08/21/2024$1.24$1.27+2.42%$1.27$1.21792,548 shs$98.96 million08/20/2024$1.23$1.24+0.81%$1.25$1.20372,222 shs$96.62 million08/19/2024$1.20$1.23+2.50%$1.24$1.17380,784 shs$95.84 million08/16/2024$1.19$1.20+0.84%$1.23$1.151.27 million shs$93.50 million08/15/2024$1.16$1.19+2.59%$1.24$1.18889,329 shs$92.72 million08/14/2024$1.16$1.16$1.18$1.15466,890 shs$90.39 millionWorker Strikes: Are You Prepared for What’s Coming? (Ad)Worker Strikes: Are You Prepared for What's Coming? The rapid advancement of artificial intelligence and automation is reshaping industries and posing threats to jobs, pushing America's financial system to its limits.Click here to prepare.08/13/2024$1.19$1.16-2.52%$1.21$1.16556,288 shs$90.39 million08/12/2024$1.20$1.19-0.83%$1.22$1.16499,374 shs$92.72 million08/09/2024$1.18$1.20+1.69%$1.26$1.181.30 million shs$93.50 million08/08/2024$1.16$1.18+1.72%$1.24$1.16801,926 shs$91.94 million08/07/2024$1.26$1.16-7.94%$1.30$1.161.05 million shs$90.39 million08/06/2024$1.26$1.26$1.32$1.26475,288 shs$98.18 million08/05/2024$1.31$1.26-3.82%$1.27$1.21917,572 shs$98.18 million08/02/2024$1.34$1.31-2.24%$1.33$1.28572,315 shs$102.08 million08/01/2024$1.38$1.34-2.90%$1.40$1.34391,192 shs$104.41 million07/31/2024$1.38$1.38$1.44$1.35517,044 shs$107.53 million07/30/2024$1.42$1.38-2.82%$1.44$1.37748,105 shs$107.53 million07/29/2024$1.50$1.42-5.33%$1.50$1.40488,618 shs$110.65 million07/26/2024$1.42$1.50+5.63%$1.51$1.43572,223 shs$116.88 million07/25/2024$1.40$1.42+1.43%$1.46$1.38512,570 shs$110.65 million07/24/2024$1.44$1.40-2.78%$1.48$1.39411,225 shs$109.09 million07/23/2024$1.45$1.44-0.69%$1.48$1.40715,615 shs$112.21 million07/22/2024$1.38$1.45+5.07%$1.46$1.38360,481 shs$112.98 million07/19/2024$1.36$1.38+1.47%$1.38$1.32426,844 shs$107.53 million07/18/2024$1.44$1.36-5.56%$1.47$1.36615,338 shs$105.97 million07/17/2024$1.51$1.44-4.64%$1.51$1.41456,672 shs$112.21 million07/16/2024$1.41$1.51+7.09%$1.52$1.41855,994 shs$117.66 million07/15/2024$1.42$1.41-0.70%$1.46$1.37660,696 shs$109.87 million07/12/2024$1.40$1.42+1.43%$1.47$1.382.81 million shs$110.65 million07/11/2024$1.31$1.40+6.87%$1.42$1.321.17 million shs$109.09 million07/10/2024$1.35$1.31-2.96%$1.38$1.28873,218 shs$102.08 million07/09/2024$1.30$1.35+3.85%$1.37$1.29535,769 shs$105.19 million07/08/2024$1.29$1.30+0.78%$1.39$1.291.15 million shs$101.30 million Related Companies: DURECT Stock Chart MEI Pharma Stock Chart Biomea Fusion Stock Chart biote Stock Chart GH Research Stock Chart Lyell Immunopharma Stock Chart Corvus Pharmaceuticals Stock Chart Voyager Therapeutics Stock Chart Galecto Stock Chart Inozyme Pharma Stock Chart Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTMX) was last updated on 10/9/2024 by MarketBeat.com Staff From Our PartnersBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Pl...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.